(Q43186682)

15 November 2017

title

Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

15 November 2017

0 references

1 reference

1 reference

5

1 reference

15 November 2017

Mei-Jou Chen

1

0 references

Hsin-Fu Chen

Hsin-Fu Chen

3

0 references

Shee-uan Chen

Shee-Uan Chen

7

0 references

Wei-shiung Yang

Wei-Shiung Yang

2

0 references

Yu-Shih Yang

Yu-Shih Yang

6

0 references

author name string

Jahn-Jahn Kuo

4

1 reference

15 November 2017

language of work or name

English

0 references

publication date

20 January 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

25

1 reference

15 November 2017

issue

3

1 reference

15 November 2017

page(s)

779-785

1 reference

Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Activin A and follistatin in systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Low grade chronic inflammation in women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Follistatin (FS) in human cerebrospinal fluid and regulation of FS expression in a mouse model of meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

The polycystic ovary syndrome per se is not associated with increased chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Inflammatory markers and the risk of coronary heart disease in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Follistatin serum concentrations during full-term labour in women--significant differences between spontaneous and induced labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Hormone replacement therapy and increased plasma concentration of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Oral contraceptives and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Relationship between leptin and C-reactive protein in young Finnish adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

Production of follistatin in porcine endothelial cells: differential regulation by bacterial compounds and the synthetic glucocorticoid RU 28362

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP459

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DEP459

1 reference

15 November 2017

1 reference